A Study of Mitoxantrone Hydrochloride Liposome Injection in Patients With Advanced Pancreatic Cancer
Clinical trial NCT05100329 · UNKNOWN
Trial details
- NCT number
- NCT05100329
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-01
- Primary completion
- 2023-11-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.